Curanex Pharmaceuticals Inc CURX
5.66 USD -0.43 (-7.06%)
At closeNov 11, 2026, 4:00 PM EST
5.91 +0.25 +4.42%
After hours · Nov 11, 4:00 PM ET
5.63 Day range 5.70
3.58 52-week range 13.34
- YTD
- -14.50%
- 1 year
- -52.44%
News
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday's pre-market session. The company's market cap stands at $8.2 million. China SXT Pharmaceuticals…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market session. The market value of their outstanding shares is at $74.6 million. BNB Plus (NASDAQ:BNBX) stock…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Curanex Pharmaceuticals Q1 EPS $(0.11) Down From $(0.01) YoY Curanex Pharmaceuticals (NASDAQ:CURX) reported quarterly losses of $(0.11) per share. This is a 1000 percent decrease over losses of $(0.01) per share from the same period last year.- benzinga.com Curanex Continues To Advance Phyto-N As Lead Development Candidate, With Ulcerative Colitis As Initial Target Indication; Co. Prepares Phyto-N For Planned IND Submission In Q4 Of 2026 Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitisExpanded pipeline strategy to include cancer cachexia, a serious…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com EXCLUSIVE: Penny Stock Curanex Expands Cachexia Focus Backed By Patient Recovery Narratives Curanex highlights patient cases suggesting its lead candidate may aid cachexia and severe disease recovery.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com EXCLUSIVE: Curanex Highlights Case Study Supporting Cachexia Focus In Oncology Strategy Curanex highlights a patient case showing symptomatic improvement, supporting its strategic focus on cancer cachexia treatment.
benzinga.com EXCLUSIVE: Curanex Pipeline Expansion Signals Push Beyond Inflammation, Metabolic Diseases Curanex expands pipeline with cancer cachexia, advances Phyto-N toward IND, and reports preclinical safety data.- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Nasdaq Tumbles Over 350 Points; US Initial Jobless Claims Increase - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket 
benzinga.com What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Curanex Pharmaceuticals Announces Wanjun Zhang Appointed CFO And Treasurer Effective Jan. 1, 2026 Succeeding Haiyan Yang Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On December 31, 2025, Haiyan Yang informed Curanex…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Curanex Pharmaceuticals Announces Pricing Of $15M Initial Public Offering Of 3.75M Shares At A Price Of $4/Share Curanex Pharmaceuticals Inc. (NASDAQ:CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases,…